NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 156 filers reported holding NEOGENOMICS INC in Q2 2016. The put-call ratio across all filers is 0.69 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $1,727,000 | +13.2% | 90,331 | +29.8% | 0.01% | +12.5% |
| Q2 2019 | $1,526,000 | +89.6% | 69,581 | +76.7% | 0.01% | +100.0% |
| Q1 2019 | $805,000 | +59.7% | 39,369 | -1.5% | 0.00% | +33.3% |
| Q4 2018 | $504,000 | -15.6% | 39,959 | +2.6% | 0.00% | 0.0% |
| Q3 2018 | $597,000 | +16.6% | 38,931 | -0.5% | 0.00% | 0.0% |
| Q2 2018 | $512,000 | +186.0% | 39,107 | +78.2% | 0.00% | +200.0% |
| Q1 2018 | $179,000 | -8.7% | 21,949 | -0.8% | 0.00% | 0.0% |
| Q4 2017 | $196,000 | -36.2% | 22,136 | -19.7% | 0.00% | -50.0% |
| Q3 2017 | $307,000 | +19.9% | 27,578 | -3.5% | 0.00% | 0.0% |
| Q2 2017 | $256,000 | +39.9% | 28,569 | +22.9% | 0.00% | +100.0% |
| Q1 2017 | $183,000 | -31.7% | 23,239 | -26.1% | 0.00% | -50.0% |
| Q4 2016 | $268,000 | +135.1% | 31,433 | +120.0% | 0.00% | +100.0% |
| Q2 2016 | $114,000 | – | 14,287 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 1,785,605 | $86,138,000 | 34.19% |
| PERKINS CAPITAL MANAGEMENT INC | 157,750 | $7,610,000 | 4.71% |
| Blue Water Life Science Advisors, LP | 222,222 | $10,719,000 | 3.49% |
| First Light Asset Management, LLC | 1,055,960 | $50,940,000 | 3.36% |
| Ranger Investment Management | 810,956 | $39,121,000 | 2.09% |
| Bullseye Asset Management LLC | 108,054 | $5,212,000 | 1.81% |
| Lombard Odier Asset Management (Switzerland) SA | 584,281 | $28,186,000 | 1.75% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 998,858 | $48,185,000 | 1.67% |
| EMERALD ADVISERS, LLC | 904,298 | $43,623,000 | 1.58% |
| Soleus Capital Management, L.P. | 190,556 | $9,192,000 | 1.43% |